SeaStar Medical Holding (ICU)
NASDAQ:ICU
Want to see ICU full AI Analyst Report?
Earnings Data
Report Date
Aug 18, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.97Last Year’s EPS
-1.8Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call communicated clear commercial and clinical momentum: notable YoY revenue growth (+69%), seven new hospital customers in Q1, completion of the SAVE Registry enrollment (50 patients), substantial trial progress (198/339 enrolled, ~58%) and a stronger cash position (+~79% YoY). Management emphasized high gross margins (>90%), disciplined operating spend and active FDA engagement on potential accelerated pathways. Offsetting this progress are the small absolute revenue base ($495k Q1), continued quarterly net losses (~$3.5M), dependence on ultra-rare pediatric case flow for adoption, ongoing enrollment and regulatory risks, and notable share dilution. Overall, the call presents meaningful early-stage commercial validation and clinical progress but also highlights typical execution and regulatory risks for a clinical-stage medical device company.Company Guidance
Strong QUELIMMUNE Revenue Growth
QUELIMMUNE net revenue of $495,000 in Q1 2026 versus $293,000 in Q1 2025, an increase of ~69% (nearly 70%). Management reports continued order momentum into Q2 and an annual net revenue target of approximately $2.0M for 2026.
Customer Expansion and Commercial Traction
Added 7 new hospitals in Q1 2026; company cited 17 customers overall and is pursuing a goal of 15 new customers in 2026. Management reports repeat orders and growing clinical interest driven by education and user forums.
Pivotal Trial Enrollment Progress
NEUTRALIZE-AKI pivotal trial has enrolled 198 of 339 planned patients (~58% complete). Company expects to finish enrollment around year-end 2026 and potentially report topline results mid-2027.
SAVE Registry Milestone
Completed enrollment at 50 patients in the SAVE Registry. 28-day safety analyses are underway and the company plans to request the FDA change the registry from mandatory to voluntary, which could reduce adoption friction if approved.
High Gross Margin
Reported gross profit margin of over 90% in Q1 2026 (consistent with prior three quarters).
Improved Cash Position
Cash balance of $9.3M as of March 31, 2026, up from $5.2M a year earlier (increase of ~79%), providing a stronger liquidity base versus prior year.
Disciplined Operating Spend and Improved Loss Metrics
Operating expenses were flat YoY at approximately $4.1M in Q1 2026. Net loss improved to ~$3.5M ($0.90 per share) from ~$3.8M ($4.38 per share) in Q1 2025 (net loss improvement ~8%), reflecting expense discipline and a larger share base.
Regulatory Engagement and Potential Pathways
Active discussions with the FDA on a modular PMA submission and accelerated/rapid approval pathways (including Breakthrough Device designation), which, if successful, could speed adult AKI approval and commercialization.
ICU Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ICU Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 13, 2026 | $4.60 | $4.20 | -8.70% |
Mar 25, 2026 | $2.28 | $2.79 | +22.37% |
Nov 13, 2025 | $4.60 | $3.80 | -17.39% |
Aug 13, 2025 | $7.27 | $8.80 | +20.98% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does SeaStar Medical Holding (ICU) report earnings?
SeaStar Medical Holding (ICU) is schdueled to report earning on Aug 18, 2026, After Close (Confirmed).
What is SeaStar Medical Holding (ICU) earnings time?
SeaStar Medical Holding (ICU) earnings time is at Aug 18, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ICU EPS forecast?
ICU EPS forecast for the fiscal quarter 2026 (Q2) is -0.97.